RecallRadar

FDA Drug recall D-0183-2025

Methadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed by: Hikma Pharmaceuticals USA Inc., Berkeley Heigh…

On 2025-01-15 the FDA classified a Class III recall of Methadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed by: Hikma Pharmaceuticals USA Inc., Berkeley Heigh… by West Ward Columbus, citing failed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0183-2025
ClassificationClass III
Statusongoing
Initiated2024-12-19
Published2025-01-15
Last updated2026-09-13 11:52 UTC
CompanyWest Ward Columbus
DistributionUS

Product

Methadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0709-20

Reason

Failed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.

Identifiers

ndc0054-0709-25
ndc0054-0709-20
ndc0054-0710-25
ndc0054-0710-20
code_infoLot # AC2556A; Exp. 03/2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0183-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.